COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF HIGH RISK HER2 POSITIVE BREAST CANCER

$1,987,155FY2014Department of the ArmyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators